Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05643001

Precision Clinical and Genetic Tools for Brain Health in Hemorrhagic Stroke

Conditions: Hemorrhagic Stroke

Sex: All
Ages: 18 Years – N/A
Phase: NA
Enrollment: 400
Sponsor: Massachusetts General Hospital

Location: United States

Summary

The overall goal of this study is to increase health care provider awareness for common risk factors and comorbidities in patients with hemorrhagic stroke that are related to impaired brain health, to ultimately improve patients management and associated outcomes. The specific objective is to test the performance and effectiveness of a custom electronic health record (EHR)-based notification module at time of index hospitalization and at follow-up for hemorrhagic stroke survivors, before disparities in access to outpatient care may limit opportunities to intervene.The investigators hypothesize that notification of health care providers through the EHR will increase measurements of low-density lipoprotein (LDL) and glycated hemoglogbin A1c (HbA1c) and increase evaluation and management rates for obstructive sleep apnea and hearing impairment.

Eligibility Criteria

Inclusion Criteria:Patients aged 18 years or olderPresenting with a primary diagnosis of hemorrhagic stroke admitted to Massachusetts General Hospital inpatient stroke serviceExclusion Criteria:Patients not meeting above inclusion criteriaPatients presenting with subdural or epidural hematoma

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05643001). StuddyBuddy aggregates publicly available trial information.